Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A window of opportunity phase II study of enzastaurin in chemonaive patients with asymptomatic metastatic colorectal cancer.
Glimelius B, Lahn M, Gawande S, Cleverly A, Darstein C, Musib L, Liu Y, Spindler KL, Frödin JE, Berglund A, Byström P, Qvortrup C, Jakobsen A, Pfeiffer P. Glimelius B, et al. Among authors: lahn m. Ann Oncol. 2010 May;21(5):1020-6. doi: 10.1093/annonc/mdp521. Epub 2009 Nov 9. Ann Oncol. 2010. PMID: 19901015 Free article. Clinical Trial.
Brain perfusion and permeability in patients with advanced, refractory glioblastoma treated with lomustine and the transforming growth factor-β receptor I kinase inhibitor LY2157299 monohydrate.
Sepulveda-Sanchez J, Ramos A, Hilario A, DE Velasco G, Castellano D, Garcia DE LA Torre M, Rodon J, Lahn MF. Sepulveda-Sanchez J, et al. Among authors: lahn mf. Oncol Lett. 2015 Jun;9(6):2442-2448. doi: 10.3892/ol.2015.3106. Epub 2015 Apr 8. Oncol Lett. 2015. PMID: 26137087 Free PMC article.
High levels of autotaxin and lysophosphatidic acid predict poor outcome in treatment of resectable gastric carcinoma.
Schirizzi A, Donghia R, De Nunzio V, Renna N, Centonze M, De Leonardis G, Lorusso V, Fantasia A, Coletta S, Stabile D, Ferro A, Notarnicola M, Ricci AD, Lotesoriere C, Lahn M, D'Alessandro R, Giannelli G. Schirizzi A, et al. Among authors: lahn m. Eur J Cancer. 2024 Oct 13;213:115066. doi: 10.1016/j.ejca.2024.115066. Online ahead of print. Eur J Cancer. 2024. PMID: 39426076 Free article.
The highly selective and oral phosphoinositide 3-kinase delta (PI3K-δ) inhibitor roginolisib induces apoptosis in mesothelioma cells and increases immune effector cell composition.
Kalla C, Ott G, Finotello F, Niewola-Staszkowska K, Conza GD, Lahn M, van der Veen L, Schüler J, Falkenstern-Ge R, Kopecka J, Riganti C. Kalla C, et al. Among authors: lahn m. Transl Oncol. 2024 May;43:101857. doi: 10.1016/j.tranon.2023.101857. Epub 2024 Feb 27. Transl Oncol. 2024. PMID: 38412661 Free PMC article.
Targeting T regulatory (Treg) cells in immunotherapy-resistant cancers.
Spiliopoulou P, Kaur P, Hammett T, Di Conza G, Lahn M. Spiliopoulou P, et al. Among authors: lahn m. Cancer Drug Resist. 2024 Jan 12;7:2. doi: 10.20517/cdr.2023.46. eCollection 2024. Cancer Drug Resist. 2024. PMID: 38318526 Free PMC article. Review.
142 results